Compare Eli Lilly And Co (LLY) vs SiTime Corporation (SITM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs SiTime Corporation — how do they compare? Eli Lilly And Co trades at $1,179.27 (market cap $1.04T), while SiTime Corporation trades at $612.37 (market cap $19.42B). The key difference: Eli Lilly And Co is far larger — about 53.6× SiTime Corporation's market cap, and Eli Lilly And Co pays a 0.59% dividend while SiTime Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold Eli Lilly And Co for 93 Days and SiTime Corporation for 18 Days on average.
| LLY | SITM | |
|---|---|---|
Market Cap | $1.04T | $19.42B |
Volume | 3,064,878 | 360,307 |
Sector | Health | Technology |
52-Week High | $1.28K | $901.60 |
52-Week Low | $799.57 | $252.76 |
Typical Hold Time | 93 Days | 18 Days |
Enterprise Value | $1.09T | $18.82B |
Dividend Yield | 0.59% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eli Lilly (LLY) trades at $1,169.93, down 1.58% on the day, but maintains strong bullish momentum with consistent earnings beats and robust revenue growth. The company's weight-loss drug portfolio continues to drive exceptional performance, with Q2 2026 EPS of $8.38 beating expectations by 31%. Technical indicators show bullish moving averages while fundamentals reveal impressive 83.4% gross margins and 102.44% ROE. Recent clinical trial successes for next-generation obesity treatments position Lilly for continued market leadership.
LLY presents a compelling growth story with dominant positioning in the expanding obesity/diabetes market, though elevated valuations (P/E 39.26) and regulatory risks require monitoring. Analyst consensus remains strongly bullish with $1,350 price target representing 15% upside. The primary investment thesis centers on pipeline execution and market expansion opportunities, balanced against competitive pressures and valuation concerns.
SiTime Corp (SITM) trades at $645.06, down 3.02% today but maintains strong analyst support with a $751.43 consensus price target. The stock shows bullish technical momentum with recent earnings beats and projected revenue growth from $327M in 2025 to $468M in 2026. SITM benefits from AI infrastructure demand, with Q2 2026 revenue surging 126.5% year-over-year and achieving its first GAAP profit.
Outlook remains positive with 100% analyst buy ratings and institutional accumulation, though risks include high valuation multiples (P/E 1,076, P/S 36.9) and negative 2025 net income. The company's positioning in precision timing for data centers and AI applications provides substantial growth potential, but investors should monitor execution on profitability targets and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About SiTime Corporation
SiTime Corporation is a leading provider of MEMS-based silicon timing solutions used in various electronic applications. The company’s products, including oscillators, resonators, and clock ICs, are designed to replace traditional quartz-based timing devices, offering superior performance, reliability, and smaller size in harsh environments. SiTime's solutions are adopted across high-growth markets such as 5G, data centers, industrial IoT, and automotive, positioning the company as a key enabler for next-generation electronic systems.
Read more on SITM →
